cle de peau BEAUTE THE FOUNDATION N
OCTINOXATE and TITANIUM DIOXIDE · Emulsion · Topical
Active ingredient
Active ingredients Purpose Octinoxate 3.9% Sunscreen Titanium Dioxide 3.3% Sunscreen
Purpose
Active ingredients Purpose Octinoxate 3.9% Sunscreen Titanium Dioxide 3.3% Sunscreen
Uses
Uses helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
Warnings
Warnings For external use only Do not use on damaged or broken skin When using this product keep out of eyes. Rinse with water to remove. Stop use and ask a doctor if rash occurs. Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
Do not use
Do not use on damaged or broken skin
When using this product
When using this product keep out of eyes. Rinse with water to remove.
Stop use and ask a doctor
Stop use and ask a doctor if rash occurs.
Keep out of reach of children
Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
Directions
Directions For sunscreen use: apply liberally 15 minutes before sun exposure use a water resistant sunscreen if swimming or sweating reapply at least every 2 hours Sun Protection Measures . Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher and other sun protection measures including: limit time in the sun, especially from 10 a.m. – 2 p.m. wear long-sleeve shirts, pants, hats, and sunglasses children under 6 months: Ask a doctor
Other information
Other information protect this product in this container from excessive heat and direct sun.
Inactive ingredients
Inactive Ingredients WATER▪DIMETHICONE▪BUTYLENE GLYCOL▪GLYCERIN▪CETYL ETHYLHEXANOATE▪CETYL PEG/PPG-10/1 DIMETHICONE▪NEOPENTYL GLYCOL DIHEPTANOATE▪DIPHENYLSILOXY PHENYL TRIMETHICONE▪TREHALOSE▪TOCOPHERYL ACETATE▪ARGANIA SPINOSA KERNEL OIL▪SODIUM HYALURONATE▪SODIUM DILAURAMIDOGLUTAMIDE LYSINE▪MAGNESIUM CHLORIDE▪PISTACIA LENTISCUS (MASTIC) GUM▪GLYCINE▪PEG/PPG-14/7 DIMETHYL ETHER▪BUPLEURUM FALCATUM ROOT EXTRACT▪ZANTHOXYLUM PIPERITUM PEEL EXTRACT▪THYMUS SERPYLLUM EXTRACT▪SODIUM ACETYLATED HYALURONATE▪ROSA ROXBURGHII FRUIT EXTRACT▪ANGELICA ACUTILOBA ROOT EXTRACT▪HYDROLYZED CONCHIOLIN PROTEIN▪HYDROLYZED SILK▪PERILLA OCYMOIDES LEAF EXTRACT▪DEXTRIN PALMITATE▪PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE▪ALUMINUM HYDROXIDE▪STEARIC ACID▪TRISODIUM EDTA▪HYDROXYPROPYLCELLULOSE▪PALMITIC ACID▪DIMETHYLACRYLAMIDE/SODIUM ACRYLOYLDIMETHYLTAURATE CROSSPOLYMER▪ALCOHOL▪DISTEARYLDIMONIUM CHLORIDE▪TRIETHOXYCAPRYLYLSILANE▪SYNTHETIC FLUORPHLOGOPITE▪BARIUM SULFATE▪CAPRYLIC/CAPRIC TRIGLYCERIDE▪ISOPROPYL ALCOHOL▪BHT▪SILICA▪THEANINE▪PHENOXYETHANOL▪CHLOROPHENESIN▪FRAGRANCE▪TITANIUM DIOXIDE▪IRON OXIDES▪
Questions?
Questions or Comments? Call toll free 1-800-906-7503
Label text from the FDA structured product label by SHISEIDO AMERICAS CORPORATION (revised Jan 5, 2026). Long sections are shortened; the complete label is on DailyMed.
Active ingredients
- Octinoxate in 14 products
- Titanium Dioxide in 14 products
cle de peau BEAUTE THE FOUNDATION N NDC products (14)
| NDC | Strength & form | Labeler | Type |
|---|---|---|---|
| 58411-840 | Octinoxate 1092 mg/28mL; Titanium Dioxide 924 mg/28mL Emulsion | SHISEIDO AMERICAS CORPORATION | OTC MONOGRAPH DRUG |
| 58411-841 | Octinoxate 1092 mg/28mL; Titanium Dioxide 924 mg/28mL Emulsion | SHISEIDO AMERICAS CORPORATION | OTC MONOGRAPH DRUG |
| 58411-842 | Octinoxate 1092 mg/28mL; Titanium Dioxide 924 mg/28mL Emulsion | SHISEIDO AMERICAS CORPORATION | OTC MONOGRAPH DRUG |
| 58411-843 | Octinoxate 1092 mg/28mL; Titanium Dioxide 924 mg/28mL Emulsion | SHISEIDO AMERICAS CORPORATION | OTC MONOGRAPH DRUG |
| 58411-844 | Octinoxate 1092 mg/28mL; Titanium Dioxide 924 mg/28mL Emulsion | SHISEIDO AMERICAS CORPORATION | OTC MONOGRAPH DRUG |
| 58411-845 | Octinoxate 1092 mg/28mL; Titanium Dioxide 924 mg/28mL Emulsion | SHISEIDO AMERICAS CORPORATION | OTC MONOGRAPH DRUG |
| 58411-846 | Octinoxate 1092 mg/28mL; Titanium Dioxide 924 mg/28mL Emulsion | SHISEIDO AMERICAS CORPORATION | OTC MONOGRAPH DRUG |
| 58411-847 | Octinoxate 1092 mg/28mL; Titanium Dioxide 924 mg/28mL Emulsion | SHISEIDO AMERICAS CORPORATION | OTC MONOGRAPH DRUG |
| 58411-848 | Octinoxate 1092 mg/28mL; Titanium Dioxide 924 mg/28mL Emulsion | SHISEIDO AMERICAS CORPORATION | OTC MONOGRAPH DRUG |
| 58411-849 | Octinoxate 1092 mg/28mL; Titanium Dioxide 924 mg/28mL Emulsion | SHISEIDO AMERICAS CORPORATION | OTC MONOGRAPH DRUG |
| 58411-850 | Octinoxate 1092 mg/28mL; Titanium Dioxide 924 mg/28mL Emulsion | SHISEIDO AMERICAS CORPORATION | OTC MONOGRAPH DRUG |
| 58411-851 | Octinoxate 1092 mg/28mL; Titanium Dioxide 924 mg/28mL Emulsion | SHISEIDO AMERICAS CORPORATION | OTC MONOGRAPH DRUG |
| 58411-852 | Octinoxate 1092 mg/28mL; Titanium Dioxide 924 mg/28mL Emulsion | SHISEIDO AMERICAS CORPORATION | OTC MONOGRAPH DRUG |
| 58411-853 | Octinoxate 1092 mg/28mL; Titanium Dioxide 924 mg/28mL Emulsion | SHISEIDO AMERICAS CORPORATION | OTC MONOGRAPH DRUG |
Frequently asked questions
What is cle de peau BEAUTE THE FOUNDATION N used for?
Uses helps prevent sunburn if used as directed with other sun protection measures (see Directions ), decreases the risk of skin cancer and early skin aging caused by the sun
Who makes cle de peau BEAUTE THE FOUNDATION N?
cle de peau BEAUTE THE FOUNDATION N is listed by 1 labeler in the FDA NDC directory, including SHISEIDO AMERICAS CORPORATION.